Cumberland Pharmaceuticals Inc
CPIX· Nasdaq
CPIXCumberland Pharmaceuticals Inc
Filed May 8, 2013 · 10-Q · 38 days after period end · 0001445305-13-001190
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $10.26M | $10.26M | $10.67M |
| Net Income | $854.71K | $423.21K | $721.16K |
| EPS Diluted | $0.05 | $0.02 | $0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 8, 2013 · 38 d after period end
